The legacy of Marie Skłodowska-Curie continues to inspire generations of researchers through her groundbreaking discoveries and unwavering dedication to science. Her work not only transformed our understanding of radioactivity but also opened new paths in medicine and scientific research. She is the only person to win Nobel Prizes in two different natural sciences – physics and chemistry. Moreover, in 1903, Marie Curie became the first woman ever to receive a Nobel Prize.
Are you curious about the family legacy of Marie Skłodowska-Curie? Watch the interview with Dr Hélène Langevin-Joliot, the granddaughter of Marie Curie Skłodowska.
Proudly bearing her name, since their launch, the Marie Curie Skłodowska Actions (MSCA) have supported more than 150,000 researchers at every stage of their careers – including 23 Nobel Prize laureates – helping them grow through international mobility, cross-sector collaboration, and excellent research across Europe and beyond.
The Choose Europe for Science initiative, launched by the European Commission in May 2025 as one of the key ERA Policies, aims to make Europe an even more attractive destination for researchers from around the world. By strengthening research funding, safeguarding scientific freedom, and improving conditions for international talent, the initiative seeks to reinforce Europe’s position as a global hub for excellent science and innovation.
At the heart of these efforts are the Marie Skłodowska-Curie Actions (MSCA). The project supports researchers at all stages of their careers through international mobility, training, and collaboration. MSCA will continue to play a key role in attracting and empowering the next generation of researchers who choose Europe as the place for their scientific journey.
